| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.80B | 20.75B | 19.53B | 21.31B | 22.78B | 18.59B |
| Gross Profit | 12.55B | 13.76B | 12.66B | 13.95B | 16.01B | 13.48B |
| EBITDA | 4.50B | 6.24B | 5.51B | 6.25B | 8.41B | 7.13B |
| Net Income | 2.70B | 3.57B | 3.39B | 4.94B | 6.87B | 7.44B |
Balance Sheet | ||||||
| Total Assets | 33.90B | 35.73B | 36.19B | 35.52B | 31.48B | 28.32B |
| Cash, Cash Equivalents and Short-Term Investments | 16.86B | 19.00B | 19.15B | 19.11B | 17.18B | 16.41B |
| Total Debt | 845.01M | 1.08B | 1.64B | 1.50B | 1.11B | 1.42B |
| Total Liabilities | 6.75B | 8.32B | 9.86B | 10.04B | 9.08B | 9.14B |
| Stockholders Equity | 25.61B | 25.93B | 24.94B | 23.99B | 20.92B | 17.75B |
Cash Flow | ||||||
| Free Cash Flow | 1.28B | 2.68B | 2.61B | 3.80B | 4.80B | 6.89B |
| Operating Cash Flow | 2.69B | 4.18B | 4.15B | 6.28B | 6.81B | 7.75B |
| Investing Cash Flow | -1.04B | -1.32B | 386.70M | -4.80B | -2.44B | -3.79B |
| Financing Cash Flow | -3.22B | -3.03B | -2.71B | -1.98B | -4.25B | -2.54B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$136.39B | 9.11 | 14.19% | 6.66% | 5.98% | 62.13% | |
67 Neutral | HK$56.30B | 8.37 | 23.50% | 3.26% | 2.03% | 1.43% | |
65 Neutral | HK$75.30B | 13.61 | 24.09% | 5.46% | -1.68% | 22.06% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
56 Neutral | HK$67.94B | ― | 3.79% | 3.62% | -7.36% | -107.25% | |
55 Neutral | HK$31.70B | 8.88 | 7.69% | 6.70% | -0.64% | -24.62% | |
48 Neutral | HK$3.24B | 18.39 | 2.84% | 2.90% | 0.52% | 99.51% |